Literature DB >> 33589774

Comment on: "Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project".

Mieke R Van Bockstal1,2, Louis Libbrecht3,4,5, Christine Galant3,4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33589774      PMCID： PMC8039035          DOI： 10.1038/s41416-021-01280-6

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  11 in total

1.  Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.

Authors:  Udo Rudloff; Lindsay M Jacks; Jessica I Goldberg; Christine A Wynveen; Edi Brogi; Sujata Patil; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

2.  Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.

Authors:  Alastair M Thompson; Karen Clements; Shan Cheung; Sarah E Pinder; Gill Lawrence; Elinor Sawyer; Olive Kearins; Graham R Ball; Ian Tomlinson; Andrew Hanby; Jeremy St J Thomas; Anthony J Maxwell; Matthew G Wallis; David J Dodwell
Journal:  Eur J Cancer       Date:  2018-08-06       Impact factor: 9.162

3.  Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.

Authors:  Fredrik Wärnberg; Hans Garmo; Stefan Emdin; Veronica Hedberg; Linda Adwall; Kerstin Sandelin; Anita Ringberg; Per Karlsson; Lars-Gunnar Arnesson; Harald Anderson; Karin Jirström; Lars Holmberg
Journal:  J Clin Oncol       Date:  2014-10-13       Impact factor: 44.544

4.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Authors:  Irene L Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Stewart J Anderson; Thomas B Julian; Stephanie R Land; Richard G Margolese; Sandra M Swain; Joseph P Costantino; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2011-03-11       Impact factor: 13.506

5.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.

Authors:  Mila Donker; Saskia Litière; Gustavo Werutsky; Jean-Pierre Julien; Ian S Fentiman; Roberto Agresti; Philippe Rouanet; Christine Tunon de Lara; Harry Bartelink; Nicole Duez; Emiel J T Rutgers; Nina Bijker
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

6.  The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.

Authors:  M G Wallis; K Clements; O Kearins; G Ball; J Macartney; G M Lawrence
Journal:  Br J Cancer       Date:  2012-04-19       Impact factor: 7.640

7.  HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.

Authors:  E Rakovitch; S Nofech-Mozes; W Hanna; S Narod; D Thiruchelvam; R Saskin; J Spayne; C Taylor; L Paszat
Journal:  Br J Cancer       Date:  2012-02-23       Impact factor: 7.640

Review 8.  A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.

Authors:  Mieke R Van Bockstal; Marie C Agahozo; Linetta B Koppert; Carolien H M van Deurzen
Journal:  Int J Cancer       Date:  2019-05-08       Impact factor: 7.396

9.  Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.

Authors:  Emma J Groen; Jan Hudecek; Lennart Mulder; Maartje van Seijen; Mathilde M Almekinders; Stoyan Alexov; Anikó Kovács; Ales Ryska; Zsuzsanna Varga; Francisco-Javier Andreu Navarro; Simonetta Bianchi; Willem Vreuls; Eva Balslev; Max V Boot; Janina Kulka; Ewa Chmielik; Ellis Barbé; Mathilda J de Rooij; Winand Vos; Andrea Farkas; Natalja E Leeuwis-Fedorovich; Peter Regitnig; Pieter J Westenend; Loes F S Kooreman; Cecily Quinn; Giuseppe Floris; Gábor Cserni; Paul J van Diest; Esther H Lips; Michael Schaapveld; Jelle Wesseling
Journal:  Breast Cancer Res Treat       Date:  2020-07-30       Impact factor: 4.872

10.  Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project.

Authors:  Abeer M Shaaban; Bridget Hilton; Karen Clements; Elena Provenzano; Shan Cheung; Matthew G Wallis; Elinor Sawyer; Jeremy S Thomas; Andrew M Hanby; Sarah E Pinder; Alastair M Thompson
Journal:  Br J Cancer       Date:  2020-11-17       Impact factor: 7.640
View more
  1 in total

1.  Reply to "Comment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project".

Authors:  Abeer M Shaaban; Bridget Hilton; Karen Clements; Sarah E Pinder; Alastair M Thompson
Journal:  Br J Cancer       Date:  2021-02-16       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.